ALT vs CUBE
Altimmune Inc (ALT) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ALT currently screens at market cap $527.0M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ALT and CUBE stock pages for the full models.
Not investment advice.